Alerts will be sent to your verified email
Verify Email
BPLPHARMA
|
Bharat Parenterals
|
Jagsonpal Pharma
|
Zim Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
0.41 % | n/a | 11.2 % |
|
Financials
|
|||
|
5 yr Average ROE
|
12.73 % | 11.8 % | 6.88 % |
|
5yr average Equity Multiplier
|
1.76 | 1.31 | 1.92 |
|
5yr Average Asset Turnover Ratio
|
0.86 | 1.18 | 0.96 |
|
5yr Avg Net Profit Margin
|
8.73 % | 7.67 % | 3.75 % |
|
Price to Book
|
5.09 | 4.74 | 2.21 |
|
P/E
|
69.21 | 39.53 | 30.58 |
|
5yr Avg Cash Conversion Cycle
|
122.06 Days | -6.79 Days | 35.7 Days |
|
Inventory Days
|
46.56 Days | 60.26 Days | 67.21 Days |
|
Days Receivable
|
179.99 Days | 25.87 Days | 97.06 Days |
|
Days Payable
|
95.97 Days | 67.96 Days | 149.76 Days |
|
5yr Average Interest Coverage Ratio
|
22.68 | 51.15 | 3.65 |
|
5yr Avg ROCE
|
16.02 % | 15.71 % | 13.04 % |
|
5yr Avg Operating Profit Margin
|
15.57 % | 11.17 % | 12.88 % |
|
5 yr average Debt to Equity
|
0.26 | 0.03 | 0.42 |
|
5yr CAGR Net Profit
|
-9.67 % | 29.92 % | 39.21 % |
|
5yr Average Return on Assets
|
8.0 % | 9.04 % | 3.71 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.27 % | 68.09 % | 33.26 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-1.15 % | -2.25 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bharat Parenterals
|
Jagsonpal Pharma
|
Zim Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|